Prednisone Schedule for Myasthenia Gravis

Michael P. Mcquillen, Daniel B. Drachman, Marjorie E. Seybold

Research output: Contribution to journalLetter

Abstract

Te the Editor: Although our experience with gradually increasing doses of prednisone in myasthenia gravis is limited, it differs sufficiently from that of Seybold and Drachman (N Engl J Med 290:81–84, 1974) to warrant comment. Three patients have been treated since June, 1973, with the regimen that they outline. All had moderately severe generalized weakness, including bulbar involvement. All experienced fluctuations in strength from the outset of therapy, with weakness on the days off prednisone. Fluctuations preceded by a week or more any perceptible trend toward improvement, and was such as to make swallowing marginal on the “off” day. In ….

Original languageEnglish (US)
Pages (from-to)631-632
Number of pages2
JournalNew England Journal of Medicine
Volume290
Issue number11
DOIs
StatePublished - Mar 14 1974

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Prednisone Schedule for Myasthenia Gravis'. Together they form a unique fingerprint.

  • Cite this